| Ytd | 77.85% | |
| 1y | 110.18% |
| Open | 5.82 | Prev Close | 5.78 | Low | 5.68 | High | 5.91 | Mkt Cap | 1.60B |
| Vol | 1.41M | Avg Vol | 2.82M | EPS | -0.19 | P/E | -30.42 | Forward P/E | -57.68 |
| Beta | 0.58 | Short Ratio | 3.07 | Inst. Own | 95.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 6.03 | 200-d Avg | 4.15 | 1yr Est | 7.30 |
Dimensional Fund Advisors LP boosted its holdings in shares of Maravai LifeSciences Holdings, Inc. (
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report) shares gapped down before the m
Wells Fargo analyst Evan Stampler maintains Maravai LifeSciences (NASDAQ:MRVI) with a Overweight
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript
Maravai LifeSciences (NASDAQ: MRVI) reported second-quarter 2026 revenue growth and a sharp improvem
Maravai LifeSciences NASDAQ: MRVI reported second-quarter 2026 revenue growth and a sharp improvemen
Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.02 per share versus
Maravai LifeSciences (NASDAQ:MRVI) affirms FY2026 sales outlook from $205.000 million-$215.000 milli
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global p
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider o
TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ:MRVI) and global pro
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company
TriLink, part of Maravai LifeSciences (NASDAQ: MRVI), today announced the opening of its GMP enzyme
JUPITER, Fla.--(BUSINESS WIRE)--TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announc
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services t
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life sci
Maravai LifeSciences Holdings, Inc. is upgraded to Buy, driven by operational restructuring, improve
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
Maravai LifeSciences NASDAQ: MRVI reported first-quarter fiscal 2026 results that management said ma
Maravai LifeSciences Holdings, Inc. (MRVI) came out with quarterly earnings of $0.01 per share, beat
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global p
Maravai LifeSciences (MRVI) might move higher on growing optimism about its earnings prospects, whic
Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
U.S. stocks experienced a drop as of midday trading in New York, potentially ending a prolonged stre
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
During Wednesday's session, 212 companies made new 52-week lows.
During Thursday's trading, 138 companies set new 52-week lows.
During Wednesday's trading, 517 companies set new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
During Monday's trading, 528 companies set new 52-week lows.
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report
During Friday's morning session, 137 companies made new 52-week highs.
During the morning session on Wednesday, 125 stocks hit new 52-week highs.
This morning 113 companies reached new 52-week highs.
Before 10 a.m. ET on Friday, 175 companies set new 52-week highs.
Before 10 a.m. ET Monday, 296 stocks made new 52-week highs.
Before 10 a.m. ET on Friday, 216 companies hit new 52-week highs.
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its fir
On Wednesday morning, 198 companies hit new 52-week highs.